BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32757000)

  • 1. Elevated circulating pro-inflammatory low-density granulocytes in adult-onset Still's disease.
    Liu Y; Xia C; Chen J; Fan C; He J
    Rheumatology (Oxford); 2021 Jan; 60(1):297-303. PubMed ID: 32757000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of low density granulocytes and NETosis in the pathogenesis of adult-onset Still's Disease.
    Torres-Ruiz J; Carrillo-Vázquez DA; Tapia-Rodríguez M; Garcia-Galicia JA; Alcocer-Varela J; Gómez-Martín D
    Clin Exp Rheumatol; 2019; 37 Suppl 121(6):74-82. PubMed ID: 31365336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
    Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
    Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Granulocyte Colony-stimulating Factor Levels in Patients With Active Phase of Adult-onset Still Disease.
    Liu Y; Zhang S; Xia CS; Chen J; Fan C
    J Rheumatol; 2021 May; 48(5):664-668. PubMed ID: 32934126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
    Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
    Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease.
    Kim HA; Choi B; Suh CH; Han MH; Jung JY; Sayeed HM; Kim YW; Sohn S
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations.
    Kim HA; Han JH; Kim WJ; Noh HJ; An JM; Yim H; Jung JY; Kim YS; Suh CH
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Expression of C-Type Lectin Domain Family 5-Member A (CLEC5A) and Its Relation to Inflammatory Parameters and Disease Course in Adult-Onset Still's Disease.
    Chen PK; Hsieh SL; Lan JL; Lin CC; Chang SH; Chen DY
    J Immunol Res; 2020; 2020():9473497. PubMed ID: 32377540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.
    Duan M; Shen M; Zhou Y; He Y; Guo Z; Ye C; Li J; Zhu L
    Clin Rheumatol; 2023 Jun; 42(6):1635-1643. PubMed ID: 36418508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
    Chen DY; Lan JL; Lin FJ; Hsieh TY
    Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
    Chen DY; Hsieh TY; Hsieh CW; Lin FJ; Lan JL
    Arthritis Rheum; 2007 Dec; 57(8):1530-8. PubMed ID: 18050226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum levels of interleukin-10 in adult-onset Still's disease are associated with disease activity.
    Sun Y; Wang Z; Chi H; Hu Q; Ye J; Liu H; Cheng X; Shi H; Zhou Z; Teng J; Yang C; Su Y
    Clin Rheumatol; 2019 Nov; 38(11):3205-3210. PubMed ID: 31236746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum levels of free interleukin-18 in adult-onset Still's disease.
    Girard C; Rech J; Brown M; Allali D; Roux-Lombard P; Spertini F; Schiffrin EJ; Schett G; Manger B; Bas S; Del Val G; Gabay C
    Rheumatology (Oxford); 2016 Dec; 55(12):2237-2247. PubMed ID: 27616144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of circulating microRNA-134 in adult-onset Still's disease and its use as potential biomarker.
    Liao TL; Chen YM; Hsieh CW; Chen HH; Lee HC; Hung WT; Tang KT; Chen DY
    Sci Rep; 2017 Jun; 7(1):4214. PubMed ID: 28646209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
    Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
    Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease.
    Chen DY; Lin CC; Chen YM; Lan JL; Hung WT; Chen HH; Lai KL; Hsieh CW
    Arthritis Res Ther; 2013 Mar; 15(2):R39. PubMed ID: 23497717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles.
    Navarini L; Vomero M; Currado D; Berardicurti O; Biaggi A; Marino A; Bearzi P; Corberi E; Rigon A; Arcarese L; Leuti A; Fava M; Fogolari M; Mattei A; Ruscitti P; Di Cola I; Sambuco F; Travaglino F; Angeletti S; Ursini F; Mariani E; Cipriani P; Agrò FE; Iagnocco A; Antonelli Incalzi R; Maccarrone M; Giacomelli R
    Front Immunol; 2023; 14():1148268. PubMed ID: 37153620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
    Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
    Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cytokine profiles in patients with adult onset Still's disease.
    Choi JH; Suh CH; Lee YM; Suh YJ; Lee SK; Kim SS; Nahm DH; Park HS
    J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.